|
1
|
Hunziker EB: Articular cartilage repair:
Basic science and clinical progress. A review of the current status
and prospects. Osteoarthritis Cartilage. 10:432–463. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rodriguez-Merchan EC: Regeneration of
articular cartilage of the knee. Rheumatol Int. 33:837–845. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimomura K, Ando W, Fujie H, Hart DA,
Yoshikawa H and Nakamura N: Scaffold-free tissue engineering for
injured joint surface restoration. J Exp Orthop. 5:22018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sterodimas A, de Faria J, Nicaretta B and
Pitanguy I: Tissue engineering with adipose-derived stem cells
(ADSCs): Current and future applications. J Plast Reconstr Aesthet
Surg. 63:1886–1892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng DY, Dan Y, Yang SH, Liu GH, Shao ZW,
Yang C, Xiao BJ, Liu X, Wu S, Zhang T and Chu PK: Controlled
chondrogenesis from adipose-derived stem cells by recombinant
transforming growth factor-β3 fusion protein in peptide scaffolds.
Acta Biomater. 11:191–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cui Z, Shen L, Lin Y, Wang S, Zheng D and
Tan Q: Inhibition of oxygen-glucose deprivation-induced apoptosis
of human adipose-derived stem cells by genetic modification with
antiapoptotic protein bcl-2. Aesthetic Plast Surg. 38:779–787.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu S, Chen P, Wu Y, Xiong S, Sun H, Xia
Q, Shi L, Liu H and Ouyang HW: Programmed application of
transforming growth factor β3 and rac1 inhibitor NSC23766 committed
hyaline cartilage differentiation of adipose-derived stem cells for
osteochondral defect repair. Stem Cells Transl Med. 3:1242–1251.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laverty HG, Wakefield LM, Occleston NL,
O'Kane S and Ferguson MW: TGF-beta3 and cancer: A review. Cytokine
Growth Factor Rev. 20:305–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen B, Wei A, Tao H, Diwan AD and Ma DD:
BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of
human bone marrow multipotent mesenchymal stromal cells in alginate
bead culture. Tissue Eng Part A. 15:1311–1320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dünker N, Schmitt K and Krieglstein K:
TGF-beta is required for programmed cell death in interdigital webs
of the developing mouse limb. Mech Dev. 113:111–120. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fogli M, Carlo-Stella C, Curti A, Ratta M,
Tazzari PL, Ragazzi E, Colla S, Santucci AM, Tura S and Lemoli RM:
Transforming growth factor beta3 inhibits chronic myelogenous
leukemia hematopoiesis by inducing Fas-independent apoptosis. Exp
Hematol. 28:775–783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Booth D and Potten CS: Protection against
mucosal injury by growth factors and cytokines. J Natl Cancer Inst
Monogr. 16–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mylotte LA, Duffy AM, Murphy M, O'Brien T,
Samali A, Barry F and Szegezdi E: Metabolic flexibility permits
mesenchymal stem cell survival in an ischemic environment. Stem
Cells. 26:1325–1336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang DW, Fermor B, Gimble JM, Awad HA and
Guilak F: Influence of oxygen on the proliferation and metabolism
of adipose derived adult stem cells. J Cell Physiol. 204:184–191.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
D'Amelio M, Cavallucci V and Cecconi F:
Neuronal caspase-3 signaling: Not only cell death. Cell Death
Differ. 17:1104–1114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharifi S, Barar J, Hejazi MS and Samadi
N: Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of
breast cancer cells to paclitaxel. Asian Pac J Cancer Prev.
15:8617–8622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sousa FG, Matuo R, Soares DG, Escargueil
AE, Henriques JA, Larsen AK and Saffi J: PARPs and the DNA damage
response. Carcinogenesis. 33:1433–1440. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang LJ, Chen Y, He J, Yi S, Wen L, Zhao S
and Cui GH: Effects of gambogic acid on the activation of caspase-3
and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via
the accumulation of ROS. Oncol Lett. 3:1159–1165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yue Y, Zhang P, Liu D, Yang JF, Nie C and
Yang D: Hypoxia preconditioning enhances the viability of ADSCs to
increase the survival rate of ischemic skin flaps in rats.
Aesthetic Plast Surg. 37:159–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Zhang X, Xie F, Zhang Z, van Dam
H, Zhang L and Zhou F: The regulation of TGF-β/SMAD signaling by
protein deubiquitination. Protein Cell. 5:503–517. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bian L, Zhai DY, Tous E, Rai R, Mauck RL
and Burdick JA: Enhanced MSC chondrogenesis following delivery of
TGF-β3 from alginate microspheres within hyaluronic acid hydrogels
in vitro and in vivo. Biomaterials. 32:6425–6434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He F, Xiong W, Wang Y, Li L, Liu C,
Yamagami T, Taketo MM, Zhou C and Chen Y: Epithelial Wnt/β-catenin
signaling regulates palatal shelf fusion through regulation of
Tgfβ3 expression. Dev Biol. 350:511–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dunker N, Schmitt K and Krieglstein K:
TGF-beta is required for programmed cell death in interdigital webs
of the developing mouse limb. Mech Dev. 113:111–120. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu BX, Li A, Lei L, Kaneko S, Wallace C,
Li X and Li Z: Glycoprotein A repetitions predominant (GARP)
positively regulates transforming growth factor (TGF) β3 and is
essential for mouse palatogenesis. J Biol Chem. 292:18091–18097.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haleem AM and Chu CR: Advances in tissue
engineering techniques for articular cartilage repair. Oper Tech
Orthop. 20:76–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng J, Han Y, Yan C, Tian X, Tao J, Kang
J and Li S: Overexpressing cellular repressor of E1A-stimulated
genes protects mesenchymal stem cells against hypoxia- and serum
deprivation-induced apoptosis by activation of PI3K/Akt. Apoptosis.
15:463–473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem Cells. 24:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou M, Liu J, Liu F, Liu K and Yu B: C1q
tumor necrosis factor-related protein-3 protects mesenchymal stem
cells against hypoxia- and serum deprivation-induced apoptosis
through the phosphoinositide 3-kinase/Akt pathway. Int J Mol Med.
33:97–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deschepper M, Oudina K, David B, Myrtil V,
Collet C, Bensidhoum M, Logeart-Avramoglou D and Petite H: Survival
and function of mesenchymal stem cells (MSCs) depend on glucose to
overcome exposure to long-term, severe and continuous hypoxia. J
Cell Mol Med. 15:1505–1514. 2011. View Article : Google Scholar : PubMed/NCBI
|
